Synfacts, Table of Contents Synfacts 2023; 19(03): 0305DOI: 10.1055/s-0042-1752402 Innovative Drug Discovery and Development Discovery of Selective Inhibitor and Degrader of Mutant PI3KαContributor(s): Antonia F. Stepan (Roche) , Nadine Kuhl (MSD) , Ferdinand H. Lutter (Janssen Pharmaceutica)Recommend Article Abstract Buy ArticleKey words Key wordsinavolisib - PI3K inhibitor - breast cancer - Ullmann coupling Full Text